Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer.
- DOI
- 10.3390/cancers13143404
- Published
- 2021-07-07
- Container
- Cancers (Basel)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers13143404,
title = {Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer.},
author = {Renuse S and Madamsetty VS and Mun DG and Madugundu AK and Singh S and Udainiya S and Mangalaparthi KK and Kim MS and Liu R and Kumar SR and Krasnoperov V and Truty M and Graham RP and Gill PS and Mukhopadhyay D and Pandey A.},
year = {2021},
journal = {Cancers (Basel)},
doi = {10.3390/cancers13143404},
url = {https://doi.org/10.3390/cancers13143404}
}RIS
TY - JOUR TI - Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer. AU - Renuse S AU - Madamsetty VS AU - Mun DG AU - Madugundu AK AU - Singh S AU - Udainiya S AU - Mangalaparthi KK AU - Kim MS AU - Liu R AU - Kumar SR AU - Krasnoperov V AU - Truty M AU - Graham RP AU - Gill PS AU - Mukhopadhyay D AU - Pandey A. PY - 2021 JO - Cancers (Basel) DO - 10.3390/cancers13143404 UR - https://doi.org/10.3390/cancers13143404 ER -
APA
S, R., VS, M., DG, M., AK, M., S, S., S, U., KK, M., MS, K., R, L., SR, K., V, K., M, T., RP, G., PS, G., D, M., & A., P. (2021). Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer.. Cancers (Basel). https://doi.org/10.3390/cancers13143404
Source records
- europe-pmc · retrieved 2026-09-27T03:15:44.820Z